Domov › Rakovina močového mechúra › North Carolina › Durham
Klinické štúdie Rakovina močového mechúra v meste Durham, NC
20 štúdií pre Rakovina močového mechúra hľadá účastníkov v zariadeniach v meste Durham a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Prebieha náborFáza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Prebieha náborFáza 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- a 1 ďalších
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Prebieha náborFáza 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Prebieha náborObservačná štúdia
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Prebieha náborFáza 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Prebieha náborObservačná štúdia
- UNC- Chapel Hill, Chapel Hill · 10 míľ odtiaľ
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Prebieha náborFáza 2
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Prebieha náborFáza 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 míľ odtiaľ
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Prebieha náborFáza 2/3
- Research Site, Chapel Hill · 10 míľ odtiaľ
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Prebieha náborFáza 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 míľ odtiaľ
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Prebieha náborFáza 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 míľ odtiaľ
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Prebieha náborObservačná štúdia
- University of North Carolina, Chapel Hill · 10 míľ odtiaľ
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Prebieha náborFáza 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 míľ odtiaľ
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 míľ odtiaľ
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Prebieha nábor
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 míľ odtiaľ
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Prebieha náborObservačná štúdia
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Prebieha náborFáza 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 míľ odtiaľ
Štúdie Rakovina močového mechúra v iných mestách
- New York City, NY35 štúdií
- Nashville, TN31 štúdií
- Houston, TX31 štúdií
- Dallas, TX27 štúdií
- Boston, MA26 štúdií
- Washington, DC26 štúdií
- Los Angeles, CA24 štúdií
- Baltimore, MD24 štúdií
- St. Louis, MO22 štúdií
- Philadelphia, PA21 štúdií
- Seattle, WA21 štúdií
- Edison, NJ21 štúdií
Iné štúdie v Durham
- Rakovina prsníka63 štúdií
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc39 štúdií
- Mnohonásobný myelóm37 štúdií
- Metastatická rakovina33 štúdií
- Akútna myeloidná leukémia33 štúdií
- Rakovina pľúc32 štúdií
- Rakovina prostaty32 štúdií
- Kolorektálny karcinóm28 štúdií
- Chronická lymfocytová leukémia27 štúdií
- Rakovina vaječníkov27 štúdií
- Srdcové zlyhanie26 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.